Animal Sedatives Market Size - By Drug (Phenothiazines, Alpha-2 Adrenergic, Benzodiazepines), Route of Administration (Parenteral, Oral), Application (Surgical, Diagnostic), Animal (Small, Large), Distribution, Global Forecast (2023-2032)

Animal Sedatives Market Size

Animal Sedatives Market size was valued to be USD 145.4 million in 2022 and is predicted to experience a sustainable growth of CAGR 5.5% up to 2032 due to increasing pet ownership, rising surgical procedures in animals, increasing incidences of zoonotic diseases, increasing adoption of pet insurance, increasing animal healthcare expenditure, and growing investment in veterinary product development activities.
 

An animal sedative is a medication or pharmaceutical compound that is used to cause a state of sedation in animals or to calm them. They target the central nervous system and help depress its activity, resulting in a calming effect on animals. They are used to reduce stress and fear in animals, which helps them be cooperative and manageable during veterinary treatments, surgeries, veterinary dental procedures, or the diagnosis of diseases.
 

During the pandemic, due to lockdowns, social distancing regulations, and prioritization of necessary services, many of the veterinary hospitals and clinics faced temporary closures or reductions in operations. During such situations, only severe veterinary cases were allowed to visit the veterinary clinics. This resulted in a reduction in non-emergency veterinary procedures, which eventually led to a decrease in the overall demand for animal sedatives. The pandemic caused disruption in the supply chain, including in the animal health industry. Due to this, many veterinary hospitals and clinics ran out of essential products such as medications, pet food, or protective equipment.
 

On the other hand, the COVID-19 pandemic resulted in a significant rise in pet ownership. During lockdowns, a large population sought companionship, leading to a surge in pet adoption. This increase in pet ownership has positively impacted the overall animal healthcare market.  The increasing prevalence of animal diseases leads to the increase in the demand for faster and efficient diagnostic and treatment options.
 

Animal Sedatives Driving Factors 

The increasing pet ownership is a key factor driving the progression of animal sedatives market. For instance, according to the UK Pet Food manufacturer’s Association, in 2022, about 62% of households in the UK own some kind of animal. Among them, the population of dogs was around 13 million and cat population was estimated to be around 12 million. Post the pandemic people are more aware and concerned about their pets and animal health which leads to the increasing demand for veterinary services.
 

The increasing prevalence of animal diseases resulted in growing demand for animal diagnostics and surgical procedures in animals in order to provide better treatment outcomes. Factors such as rising surgical and diagnostics procedure, the increasing incidences of zoonotic diseases, and increasing focus on animal health & animal expenditure.
 

Animal Sedatives Market Analysis

Based on drug class, the animal sedatives market is segmented into phenothiazines, alpha-2 adrenergic receptor agonists, benzodiazepines, butyrophenones, and other drug classes. In 2022, the phenothiazines segment accounted for the largest share of 39.4% in the industry. They provide sedation, muscle relaxation, and antiemetic effects in small animals. They are the most common and effective animal sedatives for cats and dogs. Acepromazine is one of the most widely used members of the phenothiazine class of sedatives. This class of drug can be administered orally or parenterally.
 

Based on route of administration, the animal sedatives market is subdivided into parenteral and oral. The parenteral segment is expected to showcase value at a CAGR of 5% by 2032. Parenteral administration of sedatives helps ensure a faster and more reliable absorption of the sedative into the bloodstream. It helps in the rapid onset of action and enables control over dosage for precise administration of sedatives. It enhances the bioavailability of sedatives, leading to higher and sufficient absorption of sedatives.
 

Based on application, the animal sedatives market is classified into surgical procedures, diagnostic procedures, clinical research studies and other applications. In 2022, surgical procedures segment was valued to be around USD 59.2 million. The sedatives are commonly used to facilitate animal surgical procedures in veterinary medicines. They help in reducing the anxiety and fear in animals making them manageable and ease to handle while performing the surgical procedures. They help to calm them and ensures safety of animals as well as the staff.
 

Based on animal type, the animal sedatives market is subdivided into small animals and large animals. The small animal segment is further subdivided into dogs, cats, and other small animals. The large animal segment is further subdivided into cattle, horses, and other large animals. The small animal segment comprised of the largest market share of 73.9%, in 2022. The key factors supporting the expansion of this segment are the rapidly increasing pet ownership, the high prevalence of zoonotic diseases, the increasing adoption of pet insurance, and the increasing need of diagnostics and adequate treatment.
 

Based on distribution channel, the animal sedatives market is classified into hospital pharmacies, retail pharmacies, and other distribution channels. The hospital pharmacies segment held the largest market share of 52.9% in 2022. The increasing prevalence of zoonotic diseases, the growing need of diagnostics, the increasing number of visits to veterinary hospitals and clinics, and the increasing number of veterinary practitioners.
 

Based on the region, In 2022, the North American animal sedatives market is expected to reach USD 103.4 million by 2032. This is because of a significant population of pets, well-established veterinary infrastructure, high utilization of animal sedatives for a wide range of applications, including diagnosis, surgical procedures, or animal handling, and increasing animal healthcare expenditure. On the other hand, the Asia Pacific industry is expected to grow at the highest CAGR of 6% by 2032.
 

Animal Sedatives Market Share

The prominent players in animal sedatives market are:

• Zoetis Inc
• Elanco Animal Health Incorporated
• Virbac
• Dechra Pharmaceuticals plc
• Orion Corporation
• Ceva Animal Health
• Bayer AG
• Chanelle Pharma
• Merck & Co. Inc 
• Boehringer Ingelheim Animal Health.
   

Animal Sedatives Industry News:

• In March 2022, the U.S. FDA approved Zenalpha (medetomidine and vatinoxan hydrochlorides injection) by Dechra Pharmaceuticals plc as a sedative for dogs that can sedate and make them comfortable while undergoing exams or certain medical procedures leading to product enhancement.
• In September 2022, Zoetis acquired Jurox Pty Limited for developing, manufacturing, and selling animal health products, leading to growth in sales and revenue of the company.

The global animal sedatives market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Drug Class

• Phenothiazines
• Alpha-2 adrenergic receptor agonist
• Benzodiazepines
• Butyrophenones
• Other drug classes

By Route of Administration

• Parenteral
• Oral

 By Application

• Surgical procedures
• Diagnostic procedures
• Clinical research studies
• Other applications

By Animal Type

• Small animals
• Dogs
• Cats
• Other small animals 
• Large animals
• Cattles
• Horses
• Other large animals

By Distribution Channel

• Hospital pharmacies
• Retail pharmacies
• Other distribution channels

 The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of Middle East & Africa